Opinion: Reducing drug prices may carry hidden costs

Half of all Canadians may get cancer in their lifetime, according to a recent Canadian Cancer Society study. Access to cutting-edge medicines for cancer, as well as for other diseases, is crucial to a healthy future for Canadians and Albertans.
We believe the drug pricing changes Health Canada proposed in May 2017 threatens access to cutting-edge medicines because of fewer clinical trials in Canada and the delay or abandonment of new breakthrough medicines for Canadians.
Driving the proposed cha